These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2501890)

  • 1. Binding of tissue plasminogen activator to vascular grafts.
    Harvey RA; Kim HC; Pincus J; Trooskin SZ; Wilcox JN; Greco RS
    Thromb Haemost; 1989 Feb; 61(1):131-6. PubMed ID: 2501890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost.
    Greco RS; Kim HC; Donetz AP; Harvey RA
    Ann Vasc Surg; 1995 Mar; 9(2):140-5. PubMed ID: 7540408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride.
    Harvey RA; Alcid DV; Greco RS
    Surgery; 1982 Sep; 92(3):504-12. PubMed ID: 7112401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of fibrinolytic system proteins with lysine-containing surfaces.
    McClung WG; Clapper DL; Anderson AB; Babcock DE; Brash JL
    J Biomed Mater Res A; 2003 Sep; 66(4):795-801. PubMed ID: 12926031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition.
    Ganguly K; Murciano JC; Westrick R; Leferovich J; Cines DB; Muzykantov VR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):158-64. PubMed ID: 17215448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic properties of lysine-derivatized polyethylene in contact with flowing whole blood (Chandler loop model).
    McClung WG; Babcock DE; Brash JL
    J Biomed Mater Res A; 2007 Jun; 81(3):644-51. PubMed ID: 17187399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S; Croucher DR; Saunders DN; Ranson M
    Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator binding to mouse cerebellar granule neurons.
    Verrall S; Seeds NW
    J Neurosci Res; 1988; 21(2-4):420-5. PubMed ID: 3145983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clot lysis mediated by cultured human microvascular endothelial cells.
    Speiser W; Anders E; Binder BR; Müller-Berghaus G
    Thromb Haemost; 1988 Dec; 60(3):463-7. PubMed ID: 3149047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of recombinant t-PA secretion from seeded vascular grafts.
    Shayani V; Newman KD; Dichek DA
    J Surg Res; 1994 Oct; 57(4):495-504. PubMed ID: 7934027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
    Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of tissue-type plasminogen activator to human melanoma cells.
    Bizik J; Stephens RW; Grofova M; Vaheri A
    J Cell Biochem; 1993 Mar; 51(3):326-35. PubMed ID: 8501135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of visceral peritoneum to abdominal surgery.
    Ivarsson ML; Falk P; Holmdahl L
    Br J Surg; 2001 Jan; 88(1):148-51. PubMed ID: 11136330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a small molecule PAI-1 inhibitor, ZK4044.
    Liang A; Wu F; Tran K; Jones SW; Deng G; Ye B; Zhao Z; Snider RM; Dole WP; Morser J; Wu Q
    Thromb Res; 2005; 115(4):341-50. PubMed ID: 15668194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.